Rigel Pharmaceuticals (NASDAQ:RIGL) Price Target Raised to $55.00 at Citigroup
Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price increased by Citigroup from $49.00 to $55.00 in a research report report published on Thursday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Several other research firms also recently weighed in on RIGL. HC Wainwright reiterated a “buy” rating […]
Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price increased by Citigroup from $49.00 to $55.00 in a research report report published on Thursday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Several other research firms also recently weighed in on RIGL. HC Wainwright reiterated a “buy” rating […]
